SIRT7 and prostate cancer: Intriguingly, the effect of SIRT7-mediated deacetylation of SMAD4 appears to exert tumor-suppressive roles in breast cancer and, as illustrated later, in oral squamous tumors [94] which sharply differ from its function in melanoma and prostate cancer [69, 83].